| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |